基本信息 产品详情 公司简介 推荐产品
  • 首页
  • 个人中心
  • 委托采购
  • 采购清单
网站主页 SLC39A7 antibody SLC39A7抗体
  • SLC39A7抗体
  • SLC39A7抗体
  • SLC39A7抗体

1/3

SLC39A7抗体

Rabbit Polyclonal SLC39A7 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
湖北 更新日期：2025-05-15

湖北瑞和宁生物科技有限公司

VIP1年
联系人：周经理
电话：027-19371278702拨打
手机：18008634902 拨打
邮箱：19384116026@163.com

产品详情:

中文名称：
SLC39A7抗体
英文名称：
Rabbit Polyclonal SLC39A7 Antibody
品牌：
艾普蒂
产地：
武汉
保存条件：
Stored at -20°C for 6453 year. Avoid repeated freeze / thaw cycles.
产品类别：
抗体
重组：
否
应用：
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性：
Human,Mouse,Rat
宿主：
Rabbit
偶联物：
无
靶点：
SLC39A7

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/25-1/100 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/1000-1/2000 Human,Mouse,Rat
   

产品详情

AliasesKE4; HKE4; ZIP7; RING5; H2-KE4; D6S115E; D6S2244E
WB Predicted band size50 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse
ImmunogenSynthetic peptide of human SLC39A7
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane 1-3: Human placenta tissue, huvec cells, mouse brain tissue, Primary antibody: P12108(SLC39A7 Antibody) at dilution 1/200, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 30 seconds    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human liver cancer tissue using P12108(SLC39A7 Antibody) at dilution 1/25. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human tonsil tissue using P12108(SLC39A7 Antibody) at dilution 1/25. (Original magnification: ×200)    


           

参考文献

以下是关于SLC39A7抗体的示例参考文献(注：部分为假设性示例，实际文献需通过数据库验证)：

1. **"SLC39A7/ZIP7 regulates zinc homeostasis in the endoplasmic reticulum"**

*作者：Huang et al. (2020)*

**摘要**：研究利用特异性SLC39A7抗体，通过免疫印迹和免疫荧光技术，揭示了SLC39A7在内质网锌离子转运中的作用，并验证抗体在小鼠细胞模型中的特异性。

2. **"Development of a monoclonal antibody against human SLC39A7 for cancer biomarker studies"**

*作者：Smith et al. (2018)*

**摘要**：报道了一种针对人源SLC39A7蛋白的单克隆抗体的开发，通过ELISA和免疫组化验证其高特异性，并用于乳腺癌组织中SLC39A7表达水平的检测。

3. **"SLC39A7 deficiency alters hepatic zinc metabolism and promotes steatosis"**

*作者：Kim et al. (2019)*

**摘要**：利用SLC39A7抗体进行肝脏组织Western blot分析，发现基因敲除小鼠中SLC39A7蛋白缺失导致锌稳态紊乱，与脂肪肝发生相关。

4. **"Antibody-based profiling of solute carrier proteins in human tissues"**

*作者：Zhang & Andrews (2021)*

**摘要**：综述性文章，总结了包括SLC39A7在内的溶质载体家族蛋白抗体在人类组织定位研究中的应用，强调了抗体验证的重要性。

**建议**：实际文献可通过PubMed或Google Scholar以关键词“SLC39A7 antibody”、“anti-SLC39A7”检索，并筛选涉及抗体开发、验证或应用的论文。

       

背景信息

The SLC39A7 antibody targets the solute carrier family 39 member 7 (SLC39A7), a transmembrane protein also known as ZIP7. which plays a critical role in cellular zinc homeostasis. As part of the Zrt/Irt-like protein (ZIP) family, SLC39A7 facilitates zinc transport from intracellular compartments (e.g., Golgi apparatus) into the cytoplasm, ensuring proper zinc distribution for enzymatic functions, signaling pathways, and cellular processes like proliferation, apoptosis, and immune regulation. Dysregulation of SLC39A7 has been implicated in diseases such as cancer, neurodegenerative disorders, and metabolic syndromes, where altered zinc levels disrupt cellular integrity.

SLC39A7 antibodies are essential tools for studying its expression, localization, and function. They are widely used in techniques like Western blotting, immunohistochemistry, and immunofluorescence to assess protein levels in tissues or cell lines. Commercial antibodies are typically raised against specific epitopes (e.g., human SLC39A7 N-terminal or cytoplasmic domains) and validated for specificity using knockout controls or siRNA-mediated silencing. Researchers also employ these antibodies to explore SLC39A7’s role in diseases, particularly its association with endoplasmic reticulum stress, cancer metastasis, and therapy resistance. Due to post-translational modifications or splice variants, antibody validation in relevant experimental models is crucial to ensure reliability.

       
SLC39A7抗体;SLC39A7;SLC39A7 Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力， 拥有完整、科学、质量管理体系。并不断致力于技术创新，产品创新和管理创新，赢得了国内外广大用户的信任。

成立日期 (2年)
注册资本 50万(元)
员工人数 1-10人
年营业额 ￥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,化学试剂

SLC39A7抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥（北京）生物科技有限公司 VIP
  • 2025-12-29
  • 询价
内容声明
official 进入官方账号
拨打电话 立即询价